51299 Search Results


97
ATCC vanb vref atcc 51299
Vanb Vref Atcc 51299, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/51299/Enterococcus+faecalis/10__1128_slash_aac__00760___10-49-30-32
Average 97 stars, based on 1 article reviews
vanb vref atcc 51299 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

97
LGC Standards 51299
51299, supplied by LGC Standards, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/51299/51299/custom%4051299%4011032122
Average 97 stars, based on 1 article reviews
51299 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

93
DSMZ corallococcus coralloides
Myxobacteria and potential prey organisms used in predation assays.
Corallococcus Coralloides, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/51299/Corallococcus+coralloides/pmc08397742-87-11-27
Average 93 stars, based on 1 article reviews
corallococcus coralloides - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
ATCC enterococcus
Myxobacteria and potential prey organisms used in predation assays.
Enterococcus, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/51299/Enterococcus+faecalis/10__22207_slash_jpam__16__1__18-40-0-12
Average 96 stars, based on 1 article reviews
enterococcus - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
ATCC enterococcus faecalis
Myxobacteria and potential prey organisms used in predation assays.
Enterococcus Faecalis, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/51299/Enterococcus+faecalis+(Andrewes+and+Horder)+Schleifer+and+Kilpper-Balz/pm41980582-83-25-28
Average 99 stars, based on 1 article reviews
enterococcus faecalis - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

93
Addgene inc yes1 y537f overexpression vector
Engineered destabilized 3’UTR of ERBB2 degrades specific kinases implicated in ERBB2+ trastuzumab-resistant breast cancer and in ERBB2-expressing osimertinib-resistant EGFR790M non-small-cell lung cancer cells. (A) Dot blots show the phospho-kinase array pattern of the BT474 clone 5 wildtype, BT474 clone 5 vector, BT474 clone 5 desARE3’UTR ERBB2-3, and BT474 clone 5 desARE3’UTR c-MYC 2–3. The dot marked in the red box shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR ERBB2-3 and the dot marked in green boxes shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR c-MYC 2-3. Each kinase is spotted twice. (B) Bar chart shows the intensity of the phospho-kinase array dot blot for the BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), BT474 clone 5 desARE3’UTR ERBB2-3 (red bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). (C) Bar charts show <t>YES1</t> pT60 and WNK1 pT60 kinases specifically downregulated in BT474 clone 5 desARE3’UTR ERBB2-3 in red bar. Controls BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). T-test (*** p -value = 0.00413, WT, vector vs. desARE3’UTR ERBB2-3 for YES and WNK1). (D) Venn diagram shows kinases downregulated in destabilized desARE3’UTR ERBB2-3 and -30 NCI- H1975 (p = 0.02) blue (from RNA Seq), and in destabilized desARE3’UTR ERBB2-3 BT474 clone 5 (red-kinase array) and the shared kinases found downregulated in destabilized ERBB2 in both resistant cell lines WNK1 and YES1 in pink.
Yes1 Y537f Overexpression Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/51299/YES1+Y537F+(Plasmid+%2351299)/pmc10287955-76-1-5
Average 93 stars, based on 1 article reviews
yes1 y537f overexpression vector - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Avanti Polar vpc 51299
Engineered destabilized 3’UTR of ERBB2 degrades specific kinases implicated in ERBB2+ trastuzumab-resistant breast cancer and in ERBB2-expressing osimertinib-resistant EGFR790M non-small-cell lung cancer cells. (A) Dot blots show the phospho-kinase array pattern of the BT474 clone 5 wildtype, BT474 clone 5 vector, BT474 clone 5 desARE3’UTR ERBB2-3, and BT474 clone 5 desARE3’UTR c-MYC 2–3. The dot marked in the red box shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR ERBB2-3 and the dot marked in green boxes shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR c-MYC 2-3. Each kinase is spotted twice. (B) Bar chart shows the intensity of the phospho-kinase array dot blot for the BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), BT474 clone 5 desARE3’UTR ERBB2-3 (red bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). (C) Bar charts show <t>YES1</t> pT60 and WNK1 pT60 kinases specifically downregulated in BT474 clone 5 desARE3’UTR ERBB2-3 in red bar. Controls BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). T-test (*** p -value = 0.00413, WT, vector vs. desARE3’UTR ERBB2-3 for YES and WNK1). (D) Venn diagram shows kinases downregulated in destabilized desARE3’UTR ERBB2-3 and -30 NCI- H1975 (p = 0.02) blue (from RNA Seq), and in destabilized desARE3’UTR ERBB2-3 BT474 clone 5 (red-kinase array) and the shared kinases found downregulated in destabilized ERBB2 in both resistant cell lines WNK1 and YES1 in pink.
Vpc 51299, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/51299/VPC+51299/avanti+polar___857347p
Average 90 stars, based on 1 article reviews
vpc 51299 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

N/A
Thermo Scientific™ Culti-Loops™ are ready-to-use QC organisms recommended for use in performance testing of media, stains, reagents and identification kits, and for the evaluation of bacteriological procedures.
  Buy from Supplier

N/A
Thermo Scientific™ BactiDisks™ are lyophilized mixtures of charcoal, gelatin and microorganisms in a stable disk format.
  Buy from Supplier

N/A
VPC51299 is an effective low micromolar inhibitor containing vinyl phosphonate head groups.
  Buy from Supplier

Image Search Results


Myxobacteria and potential prey organisms used in predation assays.

Journal: The ISME Journal

Article Title: The soil microbial food web revisited: Predatory myxobacteria as keystone taxa?

doi: 10.1038/s41396-021-00958-2

Figure Lengend Snippet: Myxobacteria and potential prey organisms used in predation assays.

Article Snippet: The myxobacteria Haliangium ochraceum , Stigmatella aurantiaca , Kofleria flava , Corallococcus coralloides, and Chondromyces robustus were purchased from the German Collection of Microorganisms and Cell Cultures (DSMZ, Table ).

Techniques: Bacteria

Engineered destabilized 3’UTR of ERBB2 degrades specific kinases implicated in ERBB2+ trastuzumab-resistant breast cancer and in ERBB2-expressing osimertinib-resistant EGFR790M non-small-cell lung cancer cells. (A) Dot blots show the phospho-kinase array pattern of the BT474 clone 5 wildtype, BT474 clone 5 vector, BT474 clone 5 desARE3’UTR ERBB2-3, and BT474 clone 5 desARE3’UTR c-MYC 2–3. The dot marked in the red box shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR ERBB2-3 and the dot marked in green boxes shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR c-MYC 2-3. Each kinase is spotted twice. (B) Bar chart shows the intensity of the phospho-kinase array dot blot for the BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), BT474 clone 5 desARE3’UTR ERBB2-3 (red bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). (C) Bar charts show YES1 pT60 and WNK1 pT60 kinases specifically downregulated in BT474 clone 5 desARE3’UTR ERBB2-3 in red bar. Controls BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). T-test (*** p -value = 0.00413, WT, vector vs. desARE3’UTR ERBB2-3 for YES and WNK1). (D) Venn diagram shows kinases downregulated in destabilized desARE3’UTR ERBB2-3 and -30 NCI- H1975 (p = 0.02) blue (from RNA Seq), and in destabilized desARE3’UTR ERBB2-3 BT474 clone 5 (red-kinase array) and the shared kinases found downregulated in destabilized ERBB2 in both resistant cell lines WNK1 and YES1 in pink.

Journal: Frontiers in Genetics

Article Title: Destabilized 3’UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models

doi: 10.3389/fgene.2023.1184600

Figure Lengend Snippet: Engineered destabilized 3’UTR of ERBB2 degrades specific kinases implicated in ERBB2+ trastuzumab-resistant breast cancer and in ERBB2-expressing osimertinib-resistant EGFR790M non-small-cell lung cancer cells. (A) Dot blots show the phospho-kinase array pattern of the BT474 clone 5 wildtype, BT474 clone 5 vector, BT474 clone 5 desARE3’UTR ERBB2-3, and BT474 clone 5 desARE3’UTR c-MYC 2–3. The dot marked in the red box shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR ERBB2-3 and the dot marked in green boxes shows unique kinases downregulated only in BT474 clone 5 desARE3’UTR c-MYC 2-3. Each kinase is spotted twice. (B) Bar chart shows the intensity of the phospho-kinase array dot blot for the BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), BT474 clone 5 desARE3’UTR ERBB2-3 (red bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). (C) Bar charts show YES1 pT60 and WNK1 pT60 kinases specifically downregulated in BT474 clone 5 desARE3’UTR ERBB2-3 in red bar. Controls BT474 clone 5 wildtype (black bar), BT474 clone 5 vector (blue bar), and BT474 clone 5 desARE3’UTR c-MYC 2-3 (green bar). T-test (*** p -value = 0.00413, WT, vector vs. desARE3’UTR ERBB2-3 for YES and WNK1). (D) Venn diagram shows kinases downregulated in destabilized desARE3’UTR ERBB2-3 and -30 NCI- H1975 (p = 0.02) blue (from RNA Seq), and in destabilized desARE3’UTR ERBB2-3 BT474 clone 5 (red-kinase array) and the shared kinases found downregulated in destabilized ERBB2 in both resistant cell lines WNK1 and YES1 in pink.

Article Snippet: The YES1 Y537F overexpression vector (Addgene: 51299) was transfected into desARE3’UTR ERBB2-3 and -30 cells that have lost ERBB2 and YES1 by introduction of destabilized desARE3’UTR ERBB2.

Techniques: Expressing, Plasmid Preparation, Dot Blot, RNA Sequencing

Validation of the engineered destabilized 3’UTR of ERBB2 degradation of YES1 and WNK1 and inhibition of cancer cell migration and induction of caspase 7 in vivo in treated tumor-bearing mice. (A) Western blot show YES1 and GAPDH expression across the NCI-H1975 wildtype cells, vector, cells containing constructs desARE3’UTR ERBB2-1, -3, and -30, and wildtype trastuzumab-treated NCI-H1975 cells (n = 2). (B) Bar chart shows quantification of the YES1 expression normalized against GAPDH on NCI-H1975 wildtype cells, vector, and cells containing constructs desARE3’UTR ERBB2-1, -3, and -30 (n = 2). T-test (*** p -value = 0.0021, WT, vector vs. desARE3’UTR ERBB2-1, -3, and -30). (C) Western blot shows WNK1 and GAPDH expression across the NCI-H1975 wildtype cells, vector, cells containing constructs desARE3’UTR ERBB2-1, -3, and -30 and wildtype trastuzumab-treated NCI-H1975 cells. (D) Western blot shows YES1 and GAPDH expression across the NCI-H1975 destabilized with constructs desARE3’UTR ERBB2-3 and -30 (lanes 1 and 3) and over expressed with YES1 in lanes 2 and 4. (E) Bar charts show the wound healing closing of NCI-H1975 wildtype, vector, desARE3’UTR ERBB2-1, -3, -30, and desARE3’UTR ERBB2-30,30 overexpressed with YES1 from 0 h to 72 hrs. At 24hrs ***p = 0.00025 WT, vector vs. desARE3’UTR ERBB2-3,30. At 48 hrs ****p = 0.000018 WT, vector vs. desARE3’UTR ERBB2-3 and at 72 hrs ***p = 0.0003 WT, vector vs. desARE3’UTR ERBB2-3 and **p = 0.002 WT, vector vs. desARE3’UTR ERBB2-30. (F) Pictures depict caspase 7 expression in vivo in tumors untreated NCI-H1975 wildtype, vector, desARE3’UTR ERBB2-1, -3, and -30 and quantified in bar charts. Magnification is 60x.

Journal: Frontiers in Genetics

Article Title: Destabilized 3’UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models

doi: 10.3389/fgene.2023.1184600

Figure Lengend Snippet: Validation of the engineered destabilized 3’UTR of ERBB2 degradation of YES1 and WNK1 and inhibition of cancer cell migration and induction of caspase 7 in vivo in treated tumor-bearing mice. (A) Western blot show YES1 and GAPDH expression across the NCI-H1975 wildtype cells, vector, cells containing constructs desARE3’UTR ERBB2-1, -3, and -30, and wildtype trastuzumab-treated NCI-H1975 cells (n = 2). (B) Bar chart shows quantification of the YES1 expression normalized against GAPDH on NCI-H1975 wildtype cells, vector, and cells containing constructs desARE3’UTR ERBB2-1, -3, and -30 (n = 2). T-test (*** p -value = 0.0021, WT, vector vs. desARE3’UTR ERBB2-1, -3, and -30). (C) Western blot shows WNK1 and GAPDH expression across the NCI-H1975 wildtype cells, vector, cells containing constructs desARE3’UTR ERBB2-1, -3, and -30 and wildtype trastuzumab-treated NCI-H1975 cells. (D) Western blot shows YES1 and GAPDH expression across the NCI-H1975 destabilized with constructs desARE3’UTR ERBB2-3 and -30 (lanes 1 and 3) and over expressed with YES1 in lanes 2 and 4. (E) Bar charts show the wound healing closing of NCI-H1975 wildtype, vector, desARE3’UTR ERBB2-1, -3, -30, and desARE3’UTR ERBB2-30,30 overexpressed with YES1 from 0 h to 72 hrs. At 24hrs ***p = 0.00025 WT, vector vs. desARE3’UTR ERBB2-3,30. At 48 hrs ****p = 0.000018 WT, vector vs. desARE3’UTR ERBB2-3 and at 72 hrs ***p = 0.0003 WT, vector vs. desARE3’UTR ERBB2-3 and **p = 0.002 WT, vector vs. desARE3’UTR ERBB2-30. (F) Pictures depict caspase 7 expression in vivo in tumors untreated NCI-H1975 wildtype, vector, desARE3’UTR ERBB2-1, -3, and -30 and quantified in bar charts. Magnification is 60x.

Article Snippet: The YES1 Y537F overexpression vector (Addgene: 51299) was transfected into desARE3’UTR ERBB2-3 and -30 cells that have lost ERBB2 and YES1 by introduction of destabilized desARE3’UTR ERBB2.

Techniques: Biomarker Discovery, Inhibition, Migration, In Vivo, Western Blot, Expressing, Plasmid Preparation, Construct

Comparison of ShRNAi, CRISPR, and mRNA 3’UTR destabilization in targeting HER2 in colorectal carcinoma HCT116.

Journal: Frontiers in Genetics

Article Title: Destabilized 3’UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models

doi: 10.3389/fgene.2023.1184600

Figure Lengend Snippet: Comparison of ShRNAi, CRISPR, and mRNA 3’UTR destabilization in targeting HER2 in colorectal carcinoma HCT116.

Article Snippet: The YES1 Y537F overexpression vector (Addgene: 51299) was transfected into desARE3’UTR ERBB2-3 and -30 cells that have lost ERBB2 and YES1 by introduction of destabilized desARE3’UTR ERBB2.

Techniques: Comparison, CRISPR, Genome Wide, shRNA